| Literature DB >> 31653066 |
Bunmi K Olopade1, Solomon U Oranusi2, Obinna C Nwinyi3,4, Isiaka A Lawal5, Sefater Gbashi6, Patrick B Njobeh7.
Abstract
Montmorillonite clay has a wide range of applications, one of which includes the binding of mycotoxins in foods and feeds through adsorption. T-2 toxin, produced by some Fusarium, Myrothecium, and Stachybotrys species, causes dystrophy in the brain, heart, and kidney. Various formulations that include lemongrass essential oil-modified montmorillonite clay (LGEO-MMT), lemongrass powder (LGP), montmorillonite clay washed with 1 mM NaCl (Na-MMT), montmorillonite clay (MMT), and lemongrass powder mixed with montmorillonite clay (LGP-MMT) were applied to maize at concentrations of 8% and 12% and stored for a period of one month at 30 °C. Unmodified montmorillonite clay and LGP served as the negative controls alongside untreated maize. Fourier Transform Infrared (FTIR) spectra of the various treatments showed the major functional groups as Si-O and -OH. All treatment formulations were effective in the decontamination of T-2 toxin in maize. Accordingly, it was revealed that the inclusion of Na-MMT in maize at a concentration of 8% was most effective in decontaminating T-2 toxin by 66% in maize followed by LGP-MMT at 12% inclusion level recording a 56% decontamination of T-2 toxin in maize (p = 0.05). Montmorillonite clay can be effectively modified with plant extracts for the decontamination of T-2 toxin.Entities:
Keywords: Cymbopogon citratus; T-2 toxin; adsorption; decontamination; maize; montmorillonite clay
Year: 2019 PMID: 31653066 PMCID: PMC6891709 DOI: 10.3390/toxins11110616
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Chemical structure of T-2 toxin (R1 = OAc) adapted from European Food Safety Authority (2011).
Figure 2(a) Montmorillonite clay (MMT); this figure was published previously in Olopade et al. (2019). (b) Lemongrass powder (LGP); this figure was published previously in Olopade et al. (2019). (c) Montmorillonite clay washed with NaCl (Na-MMT); this figure was published previously in Olopade et al. (2019). (d) Montmorillonite clay with lemongrass essential oil (LGEO-MMT); this figure was published previously in Olopade et al. (2019). (e) Montmorillonite mixed with Lemongrass powder (LGP-MMT); this figure was published previously in Olopade et al. (2019).
Figure 3Fourier Transform Infrared (FTIR) spectra of LGEO-MMT, LGP, Na-MMT, MMT, and LGP-MMT.
Figure 4Evaluation of T-2 toxin after treatment with 8% of various types of modified clay for 4 weeks. LGEO-MMT: Lemongrass essential oil-modified montmorillonite clay; LGP: lemongrass powder; Na-MMT: montmorillonite clay washed with 1 mM NaCl; MMT: montmorillonite clay; LGP-MMT: lemongrass powder mixed with montmorillonite clay.
Figure 5Evaluation of T-2 toxin after treatment with 12% of various types of modified clay for 4 weeks. LGEO-MMT: Lemongrass essential oil-modified montmorillonite clay; LGP: lemongrass powder; Na-MMT: montmorillonite clay washed with 1 mM NaCl; MMT: montmorillonite clay; LGP-MMT: lemongrass powder mixed with montmorillonite clay.